2,3-dinor-thromboxane b2 has been researched along with Liver Cirrhosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Caporale, R; Carloni, V; Ciabattoni, G; Cinotti, S; Filimberti, E; Gentilini, P; Grossi, A; Laffi, G; Marra, F; Melani, L | 1 |
| Basili, S; Camastra, C; Ciabattoni, G; Cordova, C; Davì, G; Ferro, D; Giammarresi, C; Iuliano, L; Landolfi, R; Rocca, B; Santarone, S; Violi, F | 1 |
2 other study(ies) available for 2,3-dinor-thromboxane b2 and Liver Cirrhosis
| Article | Year |
|---|---|
Defective aggregation in cirrhosis is independent of in vivo platelet activation.
Topics: Aged; Blood Coagulation Tests; Female; Flow Cytometry; Humans; Liver Cirrhosis; Male; Middle Aged; Platelet Activation; Platelet Aggregation; Thromboxane B2 | 1996 |
Increased thromboxane metabolites excretion in liver cirrhosis.
Topics: Adult; Aged; Blood Platelets; Creatinine; Disease Progression; Female; Fibrin Fibrinogen Degradation Products; Fibrinolysis; Humans; Liver; Liver Cirrhosis; Male; Middle Aged; Oxidation-Reduction; Partial Thromboplastin Time; Peptide Fragments; Prothrombin; Radioimmunoassay; Thromboxane A2; Thromboxane B2 | 1998 |